FMR LLC
CIK 315066 · last filed 2026-07-24
FMR LLC is a corporate insider who has filed 164 SEC Form 4 insider transactions across 37 companies since 2009. The most recent filing, for GPCR, was dated Jul 24, 2026. Across all open-market trades the lifetime net is −$168.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $416.3M across reported positions. The firm reports its address in Boston, MA. 12 SEC filings were submitted jointly with Beam Therapeutics Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$416.30M
Companies
37
Total Filings
164
Lifetime Open-Market Net
-$168.56M
Filer Profile
Reported Address
245 SUMMER STREETBOSTON, MA 02210
Phone
(617) 570-6339
State of Incorporation
DE
Formerly Known As
FMR CORP (1994–2007)
Related Filers
Beam Therapeutics Inc. — 12 joint filings, latest 2026-06-29
SYNNEX CORP — 8 joint filings, latest 2026-08-06
PVH CORP. /DE/ — 7 joint filings, latest 2026-05-07
SITE Centers Corp. — 7 joint filings, latest 2026-08-06
WESTERN DIGITAL CORP — 7 joint filings, latest 2026-08-06
CO BRINKS — 6 joint filings, latest 2026-08-06
BRUKER CORP — 6 joint filings, latest 2026-08-06
FIRSTCASH, INC — 6 joint filings, latest 2026-08-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GPCR | 10%+ Owner | 241,275 | $38.66 | $9.33M | $0 | 13 | 2026-07-24 |
| BEAM | 10%+ Owner | 1,106,071 | $23.99 | $26.53M | -$40.83M | 15 | 2026-06-29 |
| AVLN | 10%+ Owner | 727,585 | $33.57 | $24.43M | $0 | 1 | 2026-05-05 |
| Metsera, Inc. (MTSR) Delisted | 10%+ Owner | 3,010 | $70.50 | $212.2K | -$21.5K | 6 | 2025-11-12 |
| SANA | 10%+ Owner | 4,707,423 | $3.13 | $14.73M | -$1.89M | 1 | 2025-01-10 |
| BCAX | 10,818 | $22.81 | $246.8K | $0 | 1 | 2024-09-18 | |
| Turnstone Biologics Corp. (TSBX) Delisted | 10%+ Owner | 296,396 | $0.35 | $105.2K | $0 | 2 | 2024-01-11 |
| NMRA | 1,911,729 | $1.04 | $1.99M | $0 | 1 | 2023-09-21 | |
| PRME | 98,967 | $3.13 | $309.8K | $0 | 1 | 2022-10-26 | |
| Verve Therapeutics, Inc. (VERV) Delisted | 10%+ Owner | 570,729 | $11.13 | $6.35M | -$11.30M | 9 | 2022-07-28 |
| TOST | — | $32.12 | — | $0 | 1 | 2021-11-12 | |
| XLO | 319 | $8.93 | $2.8K | $0 | 1 | 2021-10-28 | |
| RLYB | 211,798 | $16.88 | $3.57M | $0 | 1 | 2021-08-04 | |
| CRBU | 17,572 | $1.27 | $22.3K | $0 | 1 | 2021-07-29 | |
| FLYW | 7,249,056 | $17.87 | $129.54M | $0 | 1 | 2021-06-02 | |
| Orchard Therapeutics plc (ORTX) Delisted | 10%+ Owner | 409,954 | $16.70 | $6.85M | -$14.43M | 3 | 2021-02-23 |
| DTIL | 124,608 | $7.17 | $893.4K | $800.0K | 1 | 2019-04-03 | |
| ViewRay, Inc. (VRAY) Delisted | 10%+ Owner | 1,620 | $0.03 | $40 | -$26.21M | 18 | 2018-08-10 |
| Surface Oncology, Inc. (SURF) Delisted | 10%+ Owner | 1,888,986 | $1.07 | $2.02M | $0 | 1 | 2018-04-25 |
| Cogent Biosciences, Inc. (UMRX) Delisted | 1,890,701 | — | — | $1.13M | 1 | 2018-04-05 | |
| VYNE Therapeutics Inc. (MNLO) Delisted | 813,478 | — | — | $0 | 1 | 2018-01-31 | |
| DNLI | 31,969 | $21.09 | $674.2K | $0 | 1 | 2017-12-14 | |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 104 | $29.08 | $3.0K | $0 | 1 | 2017-07-06 | |
| KINETA, INC./DE (PTI) Delisted | 10%+ Owner | 12,175 | — | — | -$451.8K | 8 | 2017-03-15 |
| ACRS | 10%+ Owner | 1,931,727 | $5.32 | $10.28M | $3.61M | 6 | 2016-12-21 |
| EXA CORP (EXA) Delisted | 10%+ Owner | 0 | — | — | -$19.35M | 2 | 2016-10-11 |
| CHRS | 10%+ Owner | 361,594 | $1.33 | $480.9K | -$4.37M | 2 | 2016-08-10 |
| RGNX | 10%+ Owner | 619,376 | $8.53 | $5.28M | -$2.38M | 15 | 2016-05-18 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | 10%+ Owner | 4,893,322 | — | — | $0 | 2 | 2016-05-03 |
| Blueprint Medicines Corp (BPMC) Delisted | 10%+ Owner | 496,813 | $129.46 | $64.32M | -$16.84M | 8 | 2015-11-30 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | 10%+ Owner | 107,082 | — | — | $4.50M | 3 | 2015-03-09 |
| RARE | 10%+ Owner | 1,457,994 | $14.30 | $20.85M | $3.67M | 2 | 2014-08-05 |
| GNRC | 10%+ Owner | 763,071 | $186.99 | $142.69M | $1.28M | 1 | 2014-07-03 |
| XOOM Corp (XOOM) Delisted | 10%+ Owner | 2,619,036 | — | — | -$13.6K | 4 | 2013-08-30 |
| INSM | 10%+ Owner | 2,575 | $129.41 | $333.2K | -$17.47M | 9 | 2013-07-23 |
| IRWD | 10%+ Owner | 837,736 | $4.08 | $3.42M | -$17.62M | 12 | 2013-04-02 |
| ASIA | 10%+ Owner | 498,711 | $41.51 | $20.70M | -$10.38M | 3 | 2010-09-22 |
Recent Filings
164 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-24 | GPCR | Sell (S) | — | $0 | EDGAR |
| 2026-06-29 | BEAM | Sell (S) | −284,860 | -$10.04M | EDGAR |
| 2026-05-05 | AVLN | Conv (C) | +2,284,535 | $0 | EDGAR |
| 2026-04-16 | GPCR | Sell (S) | — | $0 | EDGAR |
| 2026-01-20 | GPCR | Sell (S) | — | $0 | EDGAR |
| 2025-12-10 | GPCR | Sell (S) | — | $0 | EDGAR |
| 2025-11-17 | — | Other (J) | −2,233,460 | $0 | |
| 2025-11-12 | Metsera, Inc. (MTSR) Delisted | Gift (G) | −860,722 | $0 | EDGAR |
| 2025-11-05 | Metsera, Inc. (MTSR) Delisted | Mixed | −570,085 | -$11.8K | EDGAR |
| 2025-10-29 | BEAM | Sell (S) | −459 | -$12.2K | EDGAR |
Showing 1–10 of 164
Page 1 of 17
Next
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.